BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 102 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 3,846,154 | $44,153,847 | 52.00% |
ORACLE INVESTMENT MANAGEMENT INC | 585,194 | $6,718,027 | 5.60% |
Fairmount Funds Management LLC | 2,543,107 | $29,194,868 | 4.63% |
Saturn V Capital Management LP | 340,163 | $3,751,030 | 3.11% |
TANG CAPITAL MANAGEMENT LLC | 1,450,000 | $16,646,000 | 2.42% |
Avoro Capital Advisors LLC | 9,050,000 | $103,894,000 | 1.55% |
AlphaCentric Advisors LLC | 125,000 | $1,435,000 | 1.42% |
Sarissa Capital Management LP | 980,288 | $11,253,706 | 1.34% |
Ghost Tree Capital, LLC | 225,000 | $2,583,000 | 1.10% |
SILVERARC CAPITAL MANAGEMENT, LLC | 272,173 | $3,124,546 | 0.89% |